$VRTX VERTEX PHARMACEUTICALS INC / MA Insider Trading Week 42/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA in week 42/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Option Exercise | M | 96.87 | 2,125 | 205,849 | 6,375 | |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 157.07 | 200 | 31,414 | 115,888 | 116.1 K to 115.9 K (-0.17 %) |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 156.24 | 850 | 132,804 | 116,088 | 116.9 K to 116.1 K (-0.73 %) |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 155.03 | 875 | 135,651 | 116,938 | 117.8 K to 116.9 K (-0.74 %) |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 154.01 | 200 | 30,802 | 117,813 | 118 K to 117.8 K (-0.17 %) |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Buy | M | 96.87 | 2,125 | 205,849 | 118,013 | 115.9 K to 118 K (+1.83 %) |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 96.87 | 1,718 | 166,423 | 5,157 | |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 157.38 | 300 | 47,214 | 114,424 | 114.7 K to 114.4 K (-0.26 %) |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 155.92 | 300 | 46,776 | 114,724 | 115 K to 114.7 K (-0.26 %) |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 154.76 | 818 | 126,594 | 115,024 | 115.8 K to 115 K (-0.71 %) |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 153.42 | 300 | 46,026 | 115,842 | 116.1 K to 115.8 K (-0.26 %) |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 96.87 | 1,718 | 166,423 | 116,142 | 114.4 K to 116.1 K (+1.50 %) |
| Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | A | 0.00 | 265 | 0 | 5,858 | |
| Oct 16 2017 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 90.29 | 2,125 | 191,866 | 23,375 | |
| Oct 16 2017 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 152.93 | 2,125 | 324,976 | 28,809 | 30.9 K to 28.8 K (-6.87 %) |
| Oct 16 2017 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 90.29 | 2,125 | 191,866 | 30,934 | 28.8 K to 30.9 K (+7.38 %) |